Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Cash from Financing Activities (2023 - 2026)

Kura Oncology has reported Cash from Financing Activities over the past 4 years, most recently at $69000.0 for Q1 2026.

  • Quarterly Cash from Financing Activities fell 51.75% to $69000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Mar 2026, down 72.23% year-over-year, with the annual reading at $1.8 million for FY2025, 98.84% down from the prior year.
  • Cash from Financing Activities was $69000.0 for Q1 2026 at Kura Oncology, down from $1.1 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $148.4 million in Q1 2024 and troughed at $69000.0 in Q1 2026.
  • The 4-year median for Cash from Financing Activities is $748500.0 (2023), against an average of $15.7 million.
  • Year-over-year, Cash from Financing Activities skyrocketed 2521.43% in 2024 and then crashed 99.9% in 2025.
  • A 4-year view of Cash from Financing Activities shows it stood at $691000.0 in 2023, then rose by 16.64% to $806000.0 in 2024, then skyrocketed by 40.82% to $1.1 million in 2025, then tumbled by 93.92% to $69000.0 in 2026.
  • Per Business Quant, the three most recent readings for KURA's Cash from Financing Activities are $69000.0 (Q1 2026), $1.1 million (Q4 2025), and $515000.0 (Q2 2025).